Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clostridium difficile immune globulin - Immuron

Drug Profile

Clostridium difficile immune globulin - Immuron

Alternative Names: DiffGAM™; IMM308

Latest Information Update: 23 Jan 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ImmuCell
  • Developer Immuron
  • Class Antibacterials; Immunoglobulins
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Clostridium difficile infections

Most Recent Events

  • 23 Jan 2015 Discontinued - Phase-II for Clostridium difficile infections in Australia (PO)
  • 30 Sep 2010 Phase-II clinical trials in Clostridium difficile infections in Australia (PO)
  • 15 Jan 2003 DiffGAM technology has been licensed to CURx outside of Europe and certain nutritional rights in North America (www.curxpharma.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top